Ecological restoration increases conservation of taxonomic and functional beta diversity of woody plants in a tropical fragmented landscape

Ecological restoration can re-establish plant species populations, enhance forested habitats extension, improve landscape connectivity, and enable biodiversity persistence within a landscape. However, the potential benefits of ecological restoration on beta diversity have never been explored. Here we use field data to investigate, for the first time, if restoration plantings enhance the taxonomic and functional plant beta diversity in a fragmented landscape of the threatened Atlantic forest. Woody species were evaluated for 320 plots established in 18 forest fragments and 14 restoration plantings within a sugarcane production landscape with low forest cover, in southeastern Brazil. Diversity metrics were assessed using the multiple incidence-data version of Hill numbers and were compared among three sets of study sites: fragments, restoration plantings and the two combined. Fragments showed higher levels of alpha diversity and proportional abundance of non-pioneer and animal-dispersed species than restoration plantings. Exotic, pioneer and non-zoochoric species were more abundant in restoration plantings, an expected result considering sites still be in the early or mid-successional stages of development. Taxonomic and functional beta diversity of trees was greatest when both areas were combined. For regenerating plants, however, beta diversity results varied according to species incidence-based frequencies. Although restoration plantings do not result in full recovery of alpha diversity, they can all together complement diversity of forest fragments at the landscape level. The findings indicate two key ecological implications for biodiversity conservation: the critical importance of forest fragments as biodiversity repositories and the positive effect of restoration efforts on landscape-scale diversity in degraded regions. These novel results highlight the importance of species selection for restoration initiatives toward species and functional attributes recognized as significantly reduced or locally rare. Overall, forest fragments and restoration plantings can act synergistically to promote recovery of plant diversity in heavily deforested agricultural landscapes451CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQCOORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPESFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPnão tem88881.064976/2014-01; 88882.305844/2018-012012/24118-8; 2013/50718-

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

The terminal complement inhibitor eculizumab was shown to improve myasthenia gravis-related symptoms in the 26-week, phase 3, randomized, double-blind, placebo-controlled REGAIN study (NCT01997229). In this 52-week sub-analysis of the open-label extension of REGAIN (NCT02301624), eculizumab's efficacy and safety were assessed in 11 Japanese and 88 Caucasian patients with anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis. For patients who had received placebo during REGAIN, treatment with open-label eculizumab resulted in generally similar outcomes in the Japanese and Caucasian populations. Rapid improvements were maintained for 52 weeks, assessed by change in score from open-label extension baseline to week 52 (mean [standard error]) using the following scales (in Japanese and Caucasian patients, respectively): Myasthenia Gravis Activities of Daily Living (−2.4 [1.34] and − 3.3 [0.65]); Quantitative Myasthenia Gravis (−2.9 [1.98] and − 4.3 [0.79]); Myasthenia Gravis Composite (−4.5 [2.63] and − 4.9 [1.19]); and Myasthenia Gravis Quality of Life 15-item questionnaire (−8.6 [5.68] and − 6.5 [1.93]). Overall, the safety of eculizumab was consistent with its known safety profile. In this interim sub-analysis, the efficacy and safety of eculizumab in Japanese and Caucasian patients were generally similar, and consistent with the overall REGAIN population